ZA202000636B - Improved dual specificity polypeptide molecule - Google Patents

Improved dual specificity polypeptide molecule

Info

Publication number
ZA202000636B
ZA202000636B ZA2020/00636A ZA202000636A ZA202000636B ZA 202000636 B ZA202000636 B ZA 202000636B ZA 2020/00636 A ZA2020/00636 A ZA 2020/00636A ZA 202000636 A ZA202000636 A ZA 202000636A ZA 202000636 B ZA202000636 B ZA 202000636B
Authority
ZA
South Africa
Prior art keywords
polypeptide molecule
dual specificity
improved dual
specificity polypeptide
improved
Prior art date
Application number
ZA2020/00636A
Other languages
English (en)
Inventor
Martin Hofmann
Felix Unverdorben
Sebastian Bunk
Dominik Maurer
Original Assignee
Paul Ehrlich Strasse 15 Tuebingen 72076 Germany
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102017115966.5A external-priority patent/DE102017115966A1/de
Priority claimed from PCT/EP2018/069151 external-priority patent/WO2019012138A1/en
Application filed by Paul Ehrlich Strasse 15 Tuebingen 72076 Germany filed Critical Paul Ehrlich Strasse 15 Tuebingen 72076 Germany
Publication of ZA202000636B publication Critical patent/ZA202000636B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2020/00636A 2017-07-14 2020-01-30 Improved dual specificity polypeptide molecule ZA202000636B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762532713P 2017-07-14 2017-07-14
DE102017115966.5A DE102017115966A1 (de) 2017-07-14 2017-07-14 Polypeptidmolekül mit verbesserter zweifacher Spezifität
DE102017119866 2017-08-30
US201862658318P 2018-04-16 2018-04-16
DE102018108995 2018-04-16
PCT/EP2018/069151 WO2019012138A1 (en) 2017-07-14 2018-07-13 POLYPEPTIDE MOLECULE WITH IMPROVED DOUBLE-SPECIFICITY

Publications (1)

Publication Number Publication Date
ZA202000636B true ZA202000636B (en) 2021-07-28

Family

ID=70848164

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/00636A ZA202000636B (en) 2017-07-14 2020-01-30 Improved dual specificity polypeptide molecule

Country Status (6)

Country Link
JP (1) JP2021019626A (enExample)
CL (2) CL2020000097A1 (enExample)
HR (1) HRP20210759T1 (enExample)
IL (2) IL272045B2 (enExample)
PH (2) PH12020500098A1 (enExample)
ZA (1) ZA202000636B (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201507424WA (en) * 2013-03-14 2015-10-29 Macrogenics Inc Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor

Also Published As

Publication number Publication date
IL272045B2 (en) 2025-10-01
IL272046A (en) 2020-03-31
HRP20210759T1 (hr) 2021-06-11
PH12020500098A1 (en) 2020-12-07
CL2020000098A1 (es) 2020-05-29
CL2020000097A1 (es) 2020-05-29
PH12020500095A1 (en) 2020-12-07
JP2021019626A (ja) 2021-02-18
IL272045B1 (en) 2025-06-01
IL272045A (en) 2020-03-31

Similar Documents

Publication Publication Date Title
ZA202000842B (en) Improved dual specificity polypeptide molecule
PT3658194T (pt) Radiomarcador e agente terapêutico de modo duplo
IL275298B1 (en) Mitochondria-targeted peptides
EP3194980A4 (en) Improved single molecule peptide sequencing
GB201719557D0 (en) Polypeptide
PL3661982T3 (pl) Kompozycja podwójnego katalizatora
GB201508337D0 (en) Novel peptides
SG10202109234YA (en) Novel peptide
GB201700557D0 (en) Novel peptides
IL271404A (en) Strains for improved protein expression
SG11202005653RA (en) Novel peptide
EP3309169A4 (en) Antibody binding specifically to isolated vimentin-derived peptide, or binding fragment of the peptide
GB201600512D0 (en) Recombinant protein production
GB201612150D0 (en) Modified peptide
EP3269808A4 (en) Improved beta-fructofuranosidase
GB201506316D0 (en) Novel peptide
ZA202000636B (en) Improved dual specificity polypeptide molecule
PL3710469T3 (pl) Polipeptydy o ulepszonej swoistości transportu arabinozy
GB201719520D0 (en) Neuroprotectvie peptide
GB201721387D0 (en) Tumstatin assay
GB201620022D0 (en) Novel peptide
GB201708471D0 (en) Polypeptide
GB201715379D0 (en) Peptides
GB201715378D0 (en) Peptides
GB201711620D0 (en) Peptides